Program Book

Download Now

Poster Board Walk PDFs

Akin Utility of a Validated Disease-Specific Measure

Dispenza The BTK inhibitor acalabrutinib

Rama Mastocytosis presenting with mast cell

Bearden Experience of Patients with Smoldering SM

Castells Study of BLU 263

Deninger Effective Control of Advanced SM

George Detection of KIT D816V

George Efficacy of Avapritinib

Kavesh Mast Cells in Bone Marrows

Liang Patterns of Organ Damage

Padulla_Agressive Systematic Mastocytosis

Padulla Diagnosis and Treatment of SM

Padulla Scabies masked SM

Rets Morphologic and immunophenotypic characteristics

Videos

Serum tryptase testing: diagnostic and technical aspects

Ultrasensitive quantitative KIT mutation testing in the diagnosis and monitoring of systemic mastocytosis

Diagnostic and technical pitfalls in mast cell flow biology

Role of immunohistochemistry in the diagnosis of mast cell disease

Bone marrow morphology in systemic mastocytosis: from quintessential to challenging

Substrates of Tryptase: Physiology and Pathology

Role of mast cells in COVID-19 infection

Intraepithelial mast cell regulation and function

Update on Mast Cell Proteases

Hematopoietic origin of mast cells

Myeloid gene mutations in advanced systemic mastocytosis

Histopathology changes during KIT inhibitor therapy

GI pathology of mast cell disease

Bone marrow and small intestinal manifestations of hereditary alpha tryptasemia

MCAS Overview

Cerebral blood flow in patients with hereditary alpha tryptasemia

Mast cell mediators in mastocytosis and HAT

COVID-19 vaccine and other issues related to mast cell activation

Anti-Siglec-6 Nanocarriers for the Targeted Delivery of Midostaurin to Mast Cells

Targeted Next-Generation Sequencing Reveals Increased Prevalence of Somatic Myeloid Mutations in Pediatric Systemic Mastocytosis Compred to Pediatric Cutaneous Mastocytosis

Overall Survival, Duration of Treatment, and Reduction in Serum Tryptase Levels in Patients with Advanced Systemic Mastocytosis Treated with Avapritinib versus Best Available Therapy

Special Session: Multidisciplinary interactive tumor board Presentation 1

Special Session: Multidisciplinary interactive tumor board Presentation 2

GI manifestations of mast cell disorders

Osteoporosis in mast cell disease

Brain dysfunction in indolent systemic mastocytosis

Advanced systemic mastocytosis

Update on the ECNM registry

Future challenges and priorities in Mastocytosis